Literature DB >> 19470913

Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?

Mark A Socinski.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19470913     DOI： 10.1200/JCO.2009.22.4345

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Maintenance therapy for metastatic non-small-cell lung cancer - the role of pemetrexed.

Authors:  Youval Katz; Robert A Somer
Journal:  Lung Cancer (Auckl)       Date:  2010-04-07

2.  Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.

Authors:  Nikolaus Magios; Farastuk Bozorgmehr; Anna-Lena Volckmar; Daniel Kazdal; Martina Kirchner; Felix J Herth; Claus-Peter Heussel; Florian Eichhorn; Michael Meister; Thomas Muley; Rami A Elshafie; Jürgen R Fischer; Martin Faehling; Mark Kriegsmann; Peter Schirmacher; Helge Bischoff; Albrecht Stenzinger; Michael Thomas; Petros Christopoulos
Journal:  Ther Adv Med Oncol       Date:  2021-03-24       Impact factor: 8.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.